Overview

Screening to Prophylax Against Clostridium Difficile Infection -

Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to evaluate whether using vancomycin orally can prevent CDI in patients who are colonized with C. diff who are admitted to the hospital and need antibiotics for another infection.
Phase:
Phase 4
Details
Lead Sponsor:
William Beaumont Hospitals
Treatments:
Vancomycin